© All rights reserved to Barnea Jaffa Lande Law offices

Together is global

High Tech / Life Sciences

Legal practice in the life sciences encompasses many aspects pertaining to the development, manufacturing, patent protection, commercialization, distribution, and sale of pharma and biotechnology products and medical devices. Our firm specializes in providing legal services to companies in the life sciences sector during all stages, from the development process to the sale of finished products. We advise on all the types of transactions unique to this sector, as well in relation to the complex and stringent regulations imposed on the sector.

 

The firm’s team provides a full spectrum of legal services to entrepreneurs, pharma and medical device companies, and companies in the biotech and biomed fields. We advise on all matters pertaining to clients’ routine operations and their engagements with other companies, research bodies, distributors, investors, and more.

 

We assist our clients during submissions of local and international grant applications, aid them in formulating IP strategies and protecting their intellectual property, and ensure they comply with regulatory obligations, such as licensing, privacy protection, compliance, ESG, and more.

 

Our legal services in the life sciences sector also include representation vis-à-vis investors, capital recruitments, and acquisition transactions. We also assist in the drafting of diverse agreements, including agreements with research entities, academic institutions, and hospitals; license agreements and technology commercialization agreements; distribution agreements; cooperation agreements; and investment agreements.

 

We also handle legal issues pertaining to the development, approval, manufacturing, promotion, and sale of drugs, dietary supplements, and medical devices; packaging; labeling and advertising; and clinical trials.

 

Additionally, we provide legal services to local and international distributors, venture capital funds, private equity funds, technology companies, companies formed in academic institutions and hospitals, and medical device companies operating in Israel and abroad.

 

Our firm was ranked in the 2023 edition of the prestigious directory The Legal 500 as a leading firm in the life sciences field.

 

 

 

Back to Technology

Insights & News - High Tech / Life Sciences:


October 2, 2022

Barnea: Representing Pronto Diagnostics and Owners in Sale to Novolog

September 8, 2022

Barnea: Representing Naveh Pharma and Bigdam Ltd in Sale to Diplomat

September 8, 2022

Barnea: Representing Neve Pharma in Sale to Diplomat for NIS 81 Million

High Tech / Life Sciences

Legal practice in the life sciences encompasses many aspects pertaining to the development, manufacturing, patent protection, commercialization, distribution, and sale of pharma and biotechnology products and medical devices. Our firm specializes in providing legal services to companies in the life sciences sector during all stages, from the development process to the sale of finished products. We advise on all the types of transactions unique to this sector, as well in relation to the complex and stringent regulations imposed on the sector.

 

The firm’s team provides a full spectrum of legal services to entrepreneurs, pharma and medical device companies, and companies in the biotech and biomed fields. We advise on all matters pertaining to clients’ routine operations and their engagements with other companies, research bodies, distributors, investors, and more.

 

We assist our clients during submissions of local and international grant applications, aid them in formulating IP strategies and protecting their intellectual property, and ensure they comply with regulatory obligations, such as licensing, privacy protection, compliance, ESG, and more.

 

Our legal services in the life sciences sector also include representation vis-à-vis investors, capital recruitments, and acquisition transactions. We also assist in the drafting of diverse agreements, including agreements with research entities, academic institutions, and hospitals; license agreements and technology commercialization agreements; distribution agreements; cooperation agreements; and investment agreements.

 

We also handle legal issues pertaining to the development, approval, manufacturing, promotion, and sale of drugs, dietary supplements, and medical devices; packaging; labeling and advertising; and clinical trials.

 

Additionally, we provide legal services to local and international distributors, venture capital funds, private equity funds, technology companies, companies formed in academic institutions and hospitals, and medical device companies operating in Israel and abroad.

 

Our firm was ranked in the 2023 edition of the prestigious directory The Legal 500 as a leading firm in the life sciences field.

 

 

 

Back to Technology

Insights & News:


October 2, 2022

Barnea: Representing Pronto Diagnostics and Owners in Sale to Novolog

September 8, 2022

Barnea: Representing Naveh Pharma and Bigdam Ltd in Sale to Diplomat

September 8, 2022

Barnea: Representing Neve Pharma in Sale to Diplomat for NIS 81 Million

Enter your email for newsletter sign up: